Condition

Impaired Cognition

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 15 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials15
Recruiting1
Common interventions15
Lead sponsors shown9
Advertisement

Clinical trials

15 shown
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast CancerNCT02290834 · 2015-03-01
RECRUITING
Comparisons of gaIt aNalyses pERformance Between the Gaitrite walkwaYsNCT04557592 · 2019-06-17
COMPLETED
Cognitive Training in Parkinson StudyNCT02920632 · 2017-09-15
COMPLETED
The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major SurgeryNCT03064308 · 2017-06-26
COMPLETED
Mirabegron in Parkinson Disease and Impaired CognitionNCT02536976 · 2015-12-01
COMPLETED
Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive DisordersNCT02936401 · 2015-03-30
COMPLETED
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714713 · 2013-06-01
COMPLETED
Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and KivexaNCT01367236 · 2013-01-01
COMPLETED
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01716975 · 2012-10-01
COMPLETED
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714661 · 2012-10-01
COMPLETED
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in SchizophreniaNCT01490567 · 2011-06-01
UNKNOWN
Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)NCT01314638 · 2010-05-01
UNKNOWN
Gait and Alzheimer Interaction Tracking (GAIT) StudyNCT01315717 · 2009-11-01
COMPLETED
Alzheimer's Disease and Related DisordersNCT01315704 · 2009-11-01
UNKNOWN
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related DisordersNCT01316562 · 2009-07-01
UNKNOWN

Trial status mix

COMPLETED10
UNKNOWN4
RECRUITING1

Phase mix

NA4
PHASE33
PHASE43
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.